PDS Biotechnology CorporationPDSBNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank31
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-32.28M
↓ 17% vs avg
Percentile
P31
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-27.64M
Historical baseline
PeriodValueYoY Change
TTM$-32.28M+7.8%
2024$-35.03M-4.1%
2023$-33.64M-30.8%
2022$-25.71M-105.9%
2021$-12.49M+5.0%
2020$-13.15M+27.2%
2019$-18.07M+45.5%
2018$-33.15M+18.5%
2017$-40.70M-26.4%
2016$-32.19M-